Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
Cytosorbents (CTSO) Stock Price & Analysis
431 Followers
CTSO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.03 - $4.59
Previous Close$3.32
Volume27.23K
Average Volume (3M)127.83K
Market Cap
$144.96M
Enterprise Value$141.07M
Total Cash (Recent Filing)$22.14M
Total Debt (Recent Filing)$18.25M
Price to Earnings (P/E)-4.4
Beta0.95
Next Earnings
May 09, 2023EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding43,157,879
10 Day Avg. Volume150,131
30 Day Avg. Volume127,835
Standard Deviation0.21
R-Squared0.04
Alpha-0.00301
Financial Highlights & Ratios
Price to Book (P/B)3.90
Price to Sales (P/S)6.96
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.80
Enterprise Value/Gross Profit9.16
Enterprise Value/Ebitda-4.64
Forecast
1Y Price Target
$5.50Price Target Upside64.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cytosorbents News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTSO FAQ
What was Cytosorbents Corp’s price range in the past 12 months?
Cytosorbents Corp lowest stock price was $1.03 and its highest was $4.59 in the past 12 months.
What is Cytosorbents Corp’s market cap?
Currently, no data Available
When is Cytosorbents Corp’s upcoming earnings report date?
Cytosorbents Corp’s upcoming earnings report date is May 09, 2023 which is in 47 days.
How were Cytosorbents Corp’s earnings last quarter?
Cytosorbents Corp released its earnings results on Mar 09, 2023. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.175 by $0.165.
Is Cytosorbents Corp overvalued?
According to Wall Street analysts Cytosorbents Corp’s price is currently Undervalued.
Does Cytosorbents Corp pay dividends?
Cytosorbents Corp does not currently pay dividends.
What is Cytosorbents Corp’s EPS estimate?
Cytosorbents Corp’s EPS estimate is -$0.13.
How many shares outstanding does Cytosorbents Corp have?
Cytosorbents Corp has 43,663,010 shares outstanding.
What happened to Cytosorbents Corp’s price movement after its last earnings report?
Cytosorbents Corp reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.175. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cytosorbents Corp?
Among the largest hedge funds holding Cytosorbents Corp’s share is Royce & Associates LLC. It holds Cytosorbents Corp’s shares valued at N/A.
---
Cytosorbents Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (64.18% Upside)
$5.50 (64.18% Upside)
Hedge Fund Trend
Decreased
By 349.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.75%
12-Months-Change
Fundamentals
Return on Equity
-67.00%
Trailing 12-Months
Asset Growth
-29.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cytosorbents Corp
CytoSorbents Corp. engages in the research and development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product include CytoSorb, ContrastSorb, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.
---
---